BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 17920185)

  • 1. Re: Paula M.J. Moonen, Judith M.J.E. Bakkers, Lambertus A.L.M. Kiemenay et al. Human papilloma virus DNA and p53 mutation analysis on bladder washes in relation to clinical outcome of bladder cancer. Eur Urol 2007;52:464-9.
    Cai T; Mazzoli S; Mondaini N; Bartoletti R
    Eur Urol; 2008 Apr; 53(4):858-9; author reply 859. PubMed ID: 17920185
    [No Abstract]   [Full Text] [Related]  

  • 2. Human papilloma virus DNA and p53 mutation analysis on bladder washes in relation to clinical outcome of bladder cancer.
    Moonen PM; Bakkers JM; Kiemeney LA; Schalken JA; Melchers WJ; Witjes JA
    Eur Urol; 2007 Aug; 52(2):464-8. PubMed ID: 17116360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumorgenesis due to papillomavirus infection was first demonstrated in rabbits and cattle early last century.
    Schmitz-Drager BJ
    Eur Urol; 2007 Aug; 52(2):468-9. PubMed ID: 17674437
    [No Abstract]   [Full Text] [Related]  

  • 4. Investigation of human papillomavirus in transitional cell carcinomas of the urinary bladder in South Africa.
    Sur M; Cooper K; Allard U
    Pathology; 2001 Feb; 33(1):17-20. PubMed ID: 11280602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of p53 tumor suppressor gene mutations and human papillomavirus infection in human bladder cancers.
    Kim KH; Kim YS
    Yonsei Med J; 1995 Sep; 36(4):322-31. PubMed ID: 7483675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunohistochemical characteristics and a degree of differentiation of urinary bladder cancer].
    Frank GA; Zavalishina LE; Andreeva IuIu
    Arkh Patol; 2002; 64(6):16-8. PubMed ID: 12534221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human papillomavirus and schistosomiasis associated bladder cancer.
    Cooper K; Haffajee Z; Taylor L
    Mol Pathol; 1997 Jun; 50(3):145-8. PubMed ID: 9292149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of human papillomavirus type 16 in tear fluid before conjunctival neoplasia excision.
    Mochizuki K; Takahashi T; Furusawa Y; Hori N; Sawada A; Hayashi S; Hirose Y
    Jpn J Ophthalmol; 2005; 49(2):176-7. PubMed ID: 15838739
    [No Abstract]   [Full Text] [Related]  

  • 9. Meta-analysis of studies analyzing the relationship between bladder cancer and infection by human papillomavirus.
    Gutiérrez J; Jiménez A; de Dios Luna J; Soto MJ; Sorlózano A
    J Urol; 2006 Dec; 176(6 Pt 1):2474-81; discussion 2481. PubMed ID: 17085133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-risk human papillomavirus (HPV) is not associated with p53 and bcl-2 expression in oral squamous cell carcinomas.
    Oliveira MC; Soares RC; Pinto LP; Souza LB; Medeiros SR; Costa Ade L
    Auris Nasus Larynx; 2009 Aug; 36(4):450-6. PubMed ID: 19124208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human papillomavirus in early laryngeal carcinoma.
    Baumann JL; Cohen S; Evjen AN; Law JH; Vadivelu S; Attia A; Schindler JS; Chung CH; Wirth PS; Meijer CJ; Snijders PJ; Yarbrough WG; Slebos RJ
    Laryngoscope; 2009 Aug; 119(8):1531-7. PubMed ID: 19489068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 gene and protein status: the role of p53 alterations in predicting outcome in patients with bladder cancer.
    George B; Datar RH; Wu L; Cai J; Patten N; Beil SJ; Groshen S; Stein J; Skinner D; Jones PA; Cote RJ
    J Clin Oncol; 2007 Dec; 25(34):5352-8. PubMed ID: 18048815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-risk human papillomavirus infections and overexpression of p53 protein as prognostic indicators in transitional cell carcinoma of the urinary bladder.
    Scher HI
    J Urol; 1994 Aug; 152(2 Pt 1):568-9. PubMed ID: 8015113
    [No Abstract]   [Full Text] [Related]  

  • 14. [Re: "Usefulness of p53 in the clinical management of bladder tumors", by S. Bernardini, E. Chabannes, H. Bittard. Prog. Urol., (2001), 11, 201-208].
    Pfister C
    Prog Urol; 2001 Sep; 11(4):761. PubMed ID: 11761706
    [No Abstract]   [Full Text] [Related]  

  • 15. Body mass index (BMI) and mutations of tumor suppressor gene p53 (TP53) in patients with urinary bladder cancer.
    Ecke TH; Schlechte HH; Gunia S; Lenk SV; Loening SA
    Urol Oncol; 2008; 26(5):470-3. PubMed ID: 18367114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. E6 and e7 gene silencing and transformed phenotype of human papillomavirus 16-positive oropharyngeal cancer cells.
    Rampias T; Sasaki C; Weinberger P; Psyrri A
    J Natl Cancer Inst; 2009 Mar; 101(6):412-23. PubMed ID: 19276448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human papilloma virus DNA detection, p53 and Ki67 expression in penile verrucous and squamous cell carcinomas in the same patient.
    Gentile V; Sciarra A; Parente U; Cardillo MR; Pierangeli A; Degener AM
    Sex Transm Dis; 2009 Jul; 36(7):417-8. PubMed ID: 19390495
    [No Abstract]   [Full Text] [Related]  

  • 18. Re: Lack of evidence for a role of human papillomaviruses in transitional cell carcinoma of the bladder.
    Tenti P; Zappatore R; Carnevali L
    J Urol; 1999 May; 161(5):1582. PubMed ID: 10210414
    [No Abstract]   [Full Text] [Related]  

  • 19. Two types of squamous cell carcinoma of the palatine tonsil characterized by distinct etiology, molecular features and outcome.
    Charfi L; Jouffroy T; de Cremoux P; Le Peltier N; Thioux M; Fréneaux P; Point D; Girod A; Rodriguez J; Sastre-Garau X
    Cancer Lett; 2008 Feb; 260(1-2):72-8. PubMed ID: 18060686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 gene mutational rate, Gleason score, and BK virus infection in prostate adenocarcinoma: Is there a correlation?
    Russo G; Anzivino E; Fioriti D; Mischitelli M; Bellizzi A; Giordano A; Autran-Gomez A; Di Monaco F; Di Silverio F; Sale P; Di Prospero L; Pietropaolo V
    J Med Virol; 2008 Dec; 80(12):2100-7. PubMed ID: 19040285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.